HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Holm Schneider Selected Research

Junctional Epidermolysis Bullosa (Epidermolysis Bullosa Letalis)

1/2019Attenuation of Severe Generalized Junctional Epidermolysis Bullosa by Systemic Treatment with Gentamicin.
11/2016Genotype, Clinical Course, and Therapeutic Decision Making in 76 Infants with Severe Generalized Junctional Epidermolysis Bullosa.
9/2011Efficiency of translation termination in humans is highly dependent upon nucleotides in the neighbourhood of a (premature) termination codon.
12/2007Biological function of laminin-5 and pathogenic impact of its deficiency.
5/2007Laminin-5-deficient human keratinocytes: defective adhesion results in a saltatory and inefficient mode of migration.
1/2005Hematopoietic stem cell transplantation and subsequent 80% skin exchange by grafts from the same donor in a patient with Herlitz disease.
1/2005Novel and recurrent mutations in the laminin-5 genes causing lethal junctional epidermolysis bullosa: molecular basis and clinical course of Herlitz disease.
10/2002Treatment of two patients with Herlitz junctional epidermolysis bullosa with artificial skin bioequivalents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Holm Schneider Research Topics

Disease

10Anhidrotic Ectodermal Dysplasia 1
01/2021 - 06/2011
8Junctional Epidermolysis Bullosa (Epidermolysis Bullosa Letalis)
01/2019 - 10/2002
3Ichthyosis (Xeroderma)
01/2021 - 01/2013
3Ectodermal Dysplasia (Aplasia Cutis Congenita)
10/2020 - 02/2014
3Fetal Growth Retardation (Intrauterine Growth Retardation)
01/2016 - 03/2008
3Fibrosis (Cirrhosis)
11/2014 - 05/2012
3Hemophilia A (Haemophilia)
10/2007 - 01/2002
2Hypohidrosis
01/2021 - 01/2019
2Anodontia (Hypodontia)
01/2021 - 01/2019
2Hyperthermia
01/2019 - 01/2018
2Systemic Scleroderma (Systemic Sclerosis)
11/2014 - 05/2012
2Disease Progression
01/2005 - 10/2002
1Fetal Diseases (Embryopathy)
01/2022
1COVID-19
01/2021
1Hypotrichosis
01/2021
1Fatigue
01/2021
1Autosomal Recessive Epidermolysis Bullosa Simplex
10/2019
1Weight Gain
01/2019
1Gliosis
01/2019
1Autosomal Recessive Hypohidrotic Ectodermal Dysplasia
01/2019
1Neoplasms (Cancer)
01/2019
1Cleft Lip (Harelip)
11/2018
1Ectrodactyly
11/2018
1Acrodermatitis enteropathica
01/2018
1Asthma (Bronchial Asthma)
08/2013
1Dry Eye Syndromes (Dry Eye Syndrome)
08/2013
1Pulmonary Hypertension
11/2009
1Sepsis (Septicemia)
11/2009
1Chronic Kidney Failure (Chronic Renal Failure)
09/2009
1Diabetes Mellitus
09/2009
1Hyperinsulinism (Hyperinsulinemia)
03/2008
1Glucose Intolerance
03/2008
1Body Weight (Weight, Body)
03/2008
1Wounds and Injuries (Trauma)
10/2002
1Refractory Anemia
10/2002
1Hypoproteinemia
10/2002

Drug/Important Bio-Agent (IBA)

10EctodysplasinsIBA
01/2021 - 08/2013
5Proteins (Proteins, Gene)FDA Link
10/2020 - 01/2002
3AntibodiesIBA
02/2014 - 01/2002
3KalininIBA
12/2007 - 01/2005
2Blocking AntibodiesIBA
01/2021 - 02/2014
2Lipoxygenase (Lipoxygenase-1)IBA
01/2021 - 01/2013
2Nonsense Codon (Nonsense Mutation)IBA
01/2019 - 09/2011
2LeptinIBA
01/2016 - 03/2008
2Transforming Growth Factors (Transforming Growth Factor)IBA
11/2014 - 05/2012
2Bleomycin (Blenoxane)FDA LinkGeneric
11/2014 - 05/2012
2CollagenIBA
11/2014 - 05/2012
2indium-bleomycinIBA
11/2014 - 11/2012
2Insulin (Novolin)FDA Link
09/2009 - 03/2008
2Nicotinamide PhosphoribosyltransferaseIBA
09/2009 - 03/2008
1Pharmaceutical PreparationsIBA
01/2022
1SARS-CoV-2 spike proteinIBA
01/2021
1LipidsIBA
01/2020
1Keratin-5 (Keratin 5)IBA
10/2019
1Cadherins (E-Cadherin)IBA
01/2019
1ConnexinsIBA
01/2019
1Edar ReceptorIBA
01/2019
1Gentamicins (Gentamicin)FDA LinkGeneric
01/2019
1Glial Fibrillary Acidic ProteinIBA
01/2019
1Keratins (Keratin)IBA
01/2019
1Pilocarpine (Ocusert)FDA LinkGeneric
11/2018
1ZincIBA
01/2018
1Orphan Nuclear ReceptorsIBA
11/2014
1Constitutive Androstane ReceptorIBA
11/2014
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
11/2014
1Monoclonal AntibodiesIBA
02/2014
14-O-carboxymethylascochlorinIBA
08/2013
1Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA
11/2012
1Cullin Proteins (Cullins)IBA
11/2012
1Oxygen (Dioxygen)IBA
11/2012
13- (5- (4- (cyclopentyloxy)- 2- hydroxybenzoyl)- 2- ((3- hydroxy- 1,2- benzisoxazol- 6- yl)methoxy)phenyl)propionic acidIBA
05/2012
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
05/2012
1Biomarkers (Surrogate Marker)IBA
06/2011
1parecoxibIBA
11/2009
1ThromboxanesIBA
11/2009
1HDL CholesterolIBA
09/2009
1CorticosteroneIBA
03/2008
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
03/2008
1Glucose (Dextrose)FDA LinkGeneric
03/2008
1CreatinineIBA
03/2008
1Biological ProductsIBA
12/2007
1Factor VIII (Coagulation Factor VIII)IBA
10/2007
1Neutralizing AntibodiesIBA
10/2007
1Messenger RNA (mRNA)IBA
01/2005
1Blood Coagulation Factors (Coagulation Factor)IBA
03/2004
1IronIBA
10/2002
1Hemoglobins (Hemoglobin)IBA
10/2002
1Blood Proteins (Serum Proteins)IBA
01/2002
1DNA (Deoxyribonucleic Acid)IBA
01/2002

Therapy/Procedure

3Therapeutics
01/2019 - 12/2007
2Artificial Skin
01/2005 - 10/2002
1Lasers (Laser)
11/2018
1Palliative Care (Palliative Therapy)
11/2016
1Ligation
03/2008
1Hematopoietic Stem Cell Transplantation
01/2005